Post-Market Clinical Follow-Up Study Plan for Cartridges of Disposable Endoscopic Linear Cutting Staplers
Launched by SUZHOU KERUI MEDICAL TECHNOLOGY CO., LTD · Jun 11, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the safety and performance of special surgical tools called disposable endoscopic linear cutting staplers. These tools are used by surgeons to cut and join tissues during various types of surgeries, such as general, gynecologic (women’s health), urologic (urinary system), and thoracic (chest) procedures. The study aims to make sure these devices work well and are safe to use by collecting information from patients who have had surgeries with these staplers in countries like Italy, Brazil, and Chile.
Adults aged 18 and older who are having either open surgery or minimally invasive surgery using these specific staplers may be eligible to join. To participate, the devices must be used during the surgery, and the surgery must be done in one of the mentioned departments. People who have conditions that make using these staplers unsafe, or who have had other similar devices used during their surgery, would not be eligible. Participants can expect their surgical outcomes and any side effects to be closely monitored to help doctors better understand how safe and effective these staplers are over time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age≥18 years old, gender unlimited;
- • 2. The surgery type shall be open or endoscopic surgery;
- • 3. The departments of surgical procedures: general, gynecologic, urologic and thoracic surgical procedures;
- • 4. Investigational devices listed in this PMCF plan must be used during surgical procedures.
- Exclusion Criteria:
- • 1. Patients with surgical contraindications to the product, e.g. use the instruments on large arteries, on ischemic or necrotic tissue, use the device on tissues with a compression thickness out of the device range;
- • 2. Concomitant with similar devices (staplers/reloads/cartridges, etc.) for resection, transection and anastomosis of surgical organ or tissues;
- • 3. The operation record is incomplete, and the information related to the main indicators cannot be extracted.
About Suzhou Kerui Medical Technology Co., Ltd
Suzhou Kerui Medical Technology Co., Ltd. is a leading innovator in the medical device industry, specializing in the development and commercialization of advanced healthcare solutions. With a strong focus on research and development, the company leverages cutting-edge technology to enhance patient outcomes and improve clinical processes. Committed to quality and regulatory compliance, Suzhou Kerui collaborates with healthcare professionals and institutions to deliver state-of-the-art medical products that address the evolving needs of the global market. Their dedication to excellence positions them as a trusted partner in clinical trials and medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ningbo, Zhejiang, Chile
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported